Propagation of Pathology through Brain Networks in Neurodegenerative Diseases: From Molecules to Clinical Phenotypes

CNS Neuroscience and Therapeutics

Volumn 21, Issue 10, 2015, Pages 754-767

  Agosta, Federica ^a   Weiler, Marina ^a,b   Filippi, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Diffusion tensor MRI; Network based neurodegeneration; Neurodegenerative diseases; Prion like proteins; Resting state functional MRI

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DIFFUSION TENSOR IMAGING; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PRION DISEASE; PROTEIN AGGREGATION; REVIEW; SENILE PLAQUE; BRAIN; METABOLISM; NERVE TRACT; PATHOLOGY; PHENOTYPE;

BRAIN; HUMANS; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; NEUROIMAGING; PHENOTYPE;

EID: 84942190754     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12410     Document Type: Review

References (133)

1. Guo JL, Lee VM. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 2014;20:130-138.
2. Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013;501:45-51.
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
4. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
5. Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20-38.
6. Brettschneider J, Del Tredici K, Irwin DJ, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014;127:423-439.
7. Greicius MD, Kimmel DL. Neuroimaging insights into network-based neurodegeneration. Curr Opin Neurol 2012;25:727-734.
8. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009;62:42-52.
9. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
10. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-279.
11. Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: Early age at onset AD spectrum. Neurology 2009;73:1571-1578.
12. Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: Clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:33-40.
13. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004;63:1168-1174.
14. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71:1227-1234.
15. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-344.
16. De Strooper B. Proteases and proteolysis in Alzheimer disease: A multifactorial view on the disease process. Physiol Rev 2010;90:465-494.
17. Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol 2013;12:609-622.
18. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297:353-356.
19. Karch CM, Cruchaga C, Goate AM. Alzheimer's disease genetics: From the bench to the clinic. Neuron 2014;83:11-26.
20. Small SA, Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: A dual pathway hypothesis. Neuron 2008;60:534-542.
21. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-368.
22. Moreno-Trevino MG, Castillo-Lopez J, Meester I. Moving away from amyloid Beta to move on in Alzheimer research. Front Aging Neurosci 2015;7:2.
23. Jack CR Jr, Holtzman DM. Biomarker modeling of Alzheimer's disease. Neuron 2013;80:1347-1358.
24. Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 2012;8:423-434.
25. Riedl L, Mackenzie IR, Forstl H, Kurz A, Diehl-Schmid J. Frontotemporal lobar degeneration: Current perspectives. Neuropsychiatr Dis Treat 2014;10:297-310.
26. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005;4:771-780.
27. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-955.
28. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: Nature of impairment and implications for assessment. Lancet Neurol 2013;12:368-380.
29. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol 2010;119:1-4.
30. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.
31. Lee EB, Lee VM, Trojanowski JQ. Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 2012;13:38-50.
32. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010;9:995-1007.
33. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
34. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
35. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9:1200-1213.
36. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 1998;95:6469-6473.
37. Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 2011;10:1015-1025.
38. Baba M, Nakajo S, Tu PH, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-884.
39. Winner B, Jappelli R, Maji SK, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 2011;108:4194-4199.
40. Soto C. Prion hypothesis: The end of the controversy? Trends Biochem Sci 2011;36:151-158.
41. Herva ME, Spillantini MG. Parkinson's disease as a member of Prion-like disorders. Virus Res 2014. doi: 10.1016/j.virusres.2014.10.016. [Epub ahead of print].
42. Recasens A, Dehay B. Alpha-synuclein spreading in Parkinson's disease. Front Neuroanat 2014;8:159.
43. Nonaka T, Masuda-Suzukake M, Arai T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 2013;4:124-134.
44. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995;34:537-541.
45. Smith SM, Fox PT, Miller KL, et al. Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A 2009;106:13040-13045.
46. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 2001;98:676-682.
47. Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247-254.
48. Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage 2001;13:1174-1185.
49. Filippi M, Agosta F, Barkhof F, et al. EFNS task force: The use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012;19:e131-e140, 1487-1501.
50. Buckner RL, Sepulcre J, Talukdar T, et al. Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009;29:1860-1873.
51. Agosta F, Pievani M, Geroldi C, Copetti M, Frisoni GB, Filippi M. Resting state fMRI in Alzheimer's disease: Beyond the default mode network. Neurobiol Aging 2012;33:1564-1578.
52. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A 2004;101:4637-4642.
53. Sorg C, Riedl V, Muhlau M, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2007;104:18760-18765.
54. Weiler M, Fukuda A, Massabki LH, et al. Default mode, executive function, and language functional connectivity networks are compromised in mild Alzheimer's disease. Curr Alzheimer Res 2014;11:274-282.
55. Petrella JR, Sheldon FC, Prince SE, Calhoun VD, Doraiswamy PM. Default mode network connectivity in stable vs progressive mild cognitive impairment. Neurology 2011;76:511-517.
56. Hedden T, Van Dijk KR, Becker JA, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 2009;29:12686-12694.
57. Sheline YI, Raichle ME, Snyder AZ, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 2010;67:584-587.
58. Machulda MM, Jones DT, Vemuri P, et al. Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol 2011;68:1131-1136.
59. Gili T, Cercignani M, Serra L, et al. Regional brain atrophy and functional disconnection across Alzheimer's disease evolution. J Neurol Neurosurg Psychiatry 2011;82:58-66.
60. Zhang HY, Wang SJ, Liu B, et al. Resting brain connectivity: Changes during the progress of Alzheimer disease. Radiology 2010;256:598-606.
61. Damoiseaux JS, Prater KE, Miller BL, Greicius MD. Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol Aging 2012;33:828 e19-828 e30.
62. Brier MR, Thomas JB, Snyder AZ, et al. Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J Neurosci 2012;32:8890-8899.
63. Lehmann M, Ghosh PM, Madison C, et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 2013;136:844-858.
64. Lehmann M, Madison CM, Ghosh PM, et al. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proc Natl Acad Sci U S A 2013;110:11606-11611.
65. Pievani M, Agosta F, Pagani E, et al. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2010;31:1862-1875.
66. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2011;32:2322 e5-2322 e18.
67. Weiler M, de Campos BM, Nogueira MH, Pereira Damasceno B, Cendes F, Balthazar ML. Structural connectivity of the default mode network and cognition in Alzheimer's disease. Psychiatry Res 2014;223:15-22.
68. Agosta F, Pievani M, Sala S, et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011;258:853-863.
69. Maier-Hein KH, Westin CF, Shenton ME, et al. Widespread white matter degeneration preceding the onset of dementia. Alzheimers Dement 2015;11:485-493.e2.
70. Agosta F, Dalla Libera D, Spinelli EG, et al. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease. Ann Neurol 2014;76:813-825.
71. Caso F, Agosta F, Mattavelli D, et al. White matter degeneration in atypical Alzheimer's disease. Radiology 2015; In press.
72. Seeley WW, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008;65:249-255.
73. Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 2007;27:2349-2356.
74. Uddin LQ. Salience processing and insular cortical function and dysfunction. Nat Rev Neurosci 2015;16:55-61.
75. Zhou J, Seeley WW. Network dysfunction in Alzheimer's disease and frontotemporal dementia: Implications for psychiatry. Biol Psychiatry 2014;75:565-573.
76. Farb NA, Grady CL, Strother S, et al. Abnormal network connectivity in frontotemporal dementia: Evidence for prefrontal isolation. Cortex 2013;49:1856-1873.
77. Filippi M, Agosta F, Scola E, et al. Functional network connectivity in the behavioral variant of frontotemporal dementia. Cortex 2013;49:2389-2401.
78. Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010;133:1352-1367.
79. Day GS, Farb NA, Tang-Wai DF, et al. Salience network resting-state activity: Prediction of frontotemporal dementia progression. JAMA Neurol 2013;70:1249-1253.
80. Agosta F, Scola E, Canu E, et al. White matter damage in frontotemporal lobar degeneration spectrum. Cereb Cortex 2012;22:2705-2714.
81. Whitwell JL, Avula R, Senjem ML, et al. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology 2010;74:1279-1287.
82. Mahoney CJ, Ridgway GR, Malone IB, et al. Profiles of white matter tract pathology in frontotemporal dementia. Hum Brain Mapp 2014;35:4163-4179.
83. Lam BY, Halliday GM, Irish M, Hodges JR, Piguet O. Longitudinal white matter changes in frontotemporal dementia subtypes. Hum Brain Mapp 2014;35:3547-3557.
84. Dopper EG, Rombouts SA, Jiskoot LC, et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology 2013;80:814-823.
85. Chiò A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: Systematic insight into structural and functional changes. Lancet Neurol 2014;13:1228-1240.
86. Mohammadi B, Kollewe K, Samii A, Krampfl K, Dengler R, Munte TF. Decreased brain activation to tongue movements in amyotrophic lateral sclerosis with bulbar involvement but not Kennedy syndrome. J Neurol 2009;256:1263-1269.
87. Jelsone-Swain LM, Fling BW, Seidler RD, Hovatter R, Gruis K, Welsh RC. Reduced interhemispheric functional connectivity in the motor cortex during rest in limb-onset amyotrophic lateral sclerosis. Front Syst Neurosci 2011;4:158.
88. Tedeschi G, Trojsi F, Tessitore A, et al. Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol Aging 2012;33:886-898.
89. Fekete T, Zach N, Mujica-Parodi LR, Turner MR. Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis. PLoS One 2013;8:e85190.
90. Verstraete E, van den Heuvel MP, Veldink JH, et al. Motor network degeneration in amyotrophic lateral sclerosis: A structural and functional connectivity study. PLoS One 2010;5:e13664.
91. Agosta F, Valsasina P, Absinta M, et al. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb Cortex 2011;21:2291-2298.
92. Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain 2011;134:3470-3479.
93. Agosta F, Canu E, Valsasina P, et al. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging 2013;34:419-427.
94. Turner MR, Kiernan MC. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 2012;13:245-250.
95. Agosta F, Canu E, Inuggi A, et al. Resting state functional connectivity alterations in primary lateral sclerosis. Neurobiol Aging 2014;35:916-925.
96. Agosta F, Galantucci S, Riva N, et al. Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum Brain Mapp 2014;35:1710-1722.
97. Bede P, Bokde AL, Byrne S, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology 2013;81:361-369.
98. Canu E, Agosta F, Galantucci S, et al. Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLoS One 2013;8:e82017.
99. Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, Hornberger M. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 2012;7:e43993.
100. Kassubek J, Muller HP, Del Tredici K, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014;137:1733-1740.
101. Pyatigorskaya N, Gallea C, Garcia-Lorenzo D, Vidailhet M, Lehericy S. A review of the use of magnetic resonance imaging in Parkinson's disease. Ther Adv Neurol Disord 2014;7:206-220.
102. Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012;135:3699-3711.
103. Kwak Y, Peltier SJ, Bohnen NI, Muller ML, Dayalu P, Seidler RD. L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: A resting state fMRI study. Front Syst Neurosci 2012;6:52.
104. Wu T, Wang L, Chen Y, Zhao C, Li K, Chan P. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease. Neurosci Lett 2009;460:6-10.
105. Yang H, Zhou XJ, Zhang MM, Zheng XN, Zhao YL, Wang J. Changes in spontaneous brain activity in early Parkinson's disease. Neurosci Lett 2013;549:24-28.
106. Choe IH, Yeo S, Chung KC, Kim SH, Lim S. Decreased and increased cerebral regional homogeneity in early Parkinson's disease. Brain Res 2013;1527:230-237.
107. Esposito F, Tessitore A, Giordano A, et al. Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. Brain 2013;136:710-725.
108. Agosta F, Caso F, Stankovic I, et al. Cortico-striatal-thalamic network functional connectivity in hemiparkinsonism. Neurobiol Aging 2014;35:2592-2602.
109. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the Parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75:481-484.
110. Zhang K, Yu C, Zhang Y, et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur J Radiol 2011;77:269-273.
111. Haller S, Badoud S, Nguyen D, Garibotto V, Lovblad KO, Burkhard PR. Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: Initial results. AJNR Am J Neuroradiol 2012;33:2123-2128.
112. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: A diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222-1226.
113. Scherfler C, Schocke MF, Seppi K, et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006;129:538-542.
114. Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 2012;33:727-739.
115. Agosta F, Canu E, Stojkovic T, et al. The topography of brain damage at different stages of Parkinson's disease. Hum Brain Mapp 2013;34:2798-2807.
116. Deng B, Zhang Y, Wang L, et al. Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson's disease. Am J Alzheimers Dis Other Demen 2013;28:154-164.
117. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function. NeuroImage 2012;62:1675-1684.
118. Agosta F, Canu E, Stefanova E, et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 2014;35:1921-1929.
119. Filippi M, van den Heuvel M, Fornito A, et al. Assessing brain system dysfunction through MRI-based connectomics. Lancet Neurol 2013;12:1189-1199.
120. He Y, Chen Z, Evans A. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease. J Neurosci 2008;28:4756-4766.
121. Supekar K, Menon V, Rubin D, Musen M, Greicius MD. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput Biol 2008;4:e1000100.
122. Tijms BM, Wink AM, de Haan W, et al. Alzheimer's disease: Connecting findings from graph theoretical studies of brain networks. Neurobiol Aging 2013;34:2023-2036.
123. Yao Z, Zhang Y, Lin L, Zhou Y, Xu C, Jiang T. Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease. PLoS Comput Biol 2010;6:e1001006.
124. Lo CY, Wang PN, Chou KH, Wang J, He Y, Lin CP. Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer's disease. J Neurosci 2010;30:16876-16885.
125. Wang J, Zuo X, Dai Z, et al. Disrupted functional brain connectome in individuals at risk for Alzheimer's disease. Biol Psychiatry 2013;73:472-481.
126. Agosta F, Sala S, Valsasina P, et al. Brain network connectivity assessed using graph theory in frontotemporal dementia. Neurology 2013;81:134-143.
127. Verstraete E, Veldink JH, Mandl RC, van den Berg LH, van den Heuvel MP. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One 2011;6:e24239.
128. Verstraete E, Veldink JH, van den Berg LH, van den Heuvel MP. Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:1351-1361.
129. Schmidt R, Verstraete E, de Reus MA, Veldink JH, van den Berg LH, van den Heuvel MP. Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:4386-4395.
130. Baggio HC, Sala-Llonch R, Segura B, et al. Functional brain networks and cognitive deficits in Parkinson's disease. Hum Brain Mapp 2014;35:4620-4634.
131. Skidmore F, Korenkevych D, Liu Y, He G, Bullmore E, Pardalos PM. Connectivity brain networks based on wavelet correlation analysis in Parkinson fMRI data. Neurosci Lett 2011;499:47-51.
132. Raj A, Kuceyeski A, Weiner M. A network diffusion model of disease progression in dementia. Neuron 2012;73:1204-1215.
133. Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 2012;73:1216-1227.